Combined_solicitation-synopsis_Revised_.pdf

Revised 1-07-2014

THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION AND A SEPARATE

SOLICITATION WILL NOT BE ISSUED.

This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.

The Solicitation Number for this acquisition is CC-P14-001231 and is being issued as a Request for Quote (RFQ). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2005-72 effective January 30, 2014. This acquisition is unrestricted. The North American Industry Classification System (NAICS) Code for this procurement is 622310 and the Small Business Size Standard is $35.5 million dollars.

STATEMENT OF OBJECTIVES

To procure the services of a board certified pediatric rehabilitation physician to provide excellent patient care and to advance rehabilitation science at the NIH with the aim of improving an individual’s ability to perform functional movement tasks.

STATEMENT OF WORK

The rehabilitation physician will work a total of 14.5 hours a week for 27 weeks a year for a total level of effort of 391.5 hours. The services provided include:

a. Clinical consultation for NIH protocols requesting gait evaluation or evaluation of other complex movement disorders through the motion analysis laboratory

b. Perform and interpret fine wire Electromyography (EMG)

c. Musculoskeletal imaging using ultrasound guided injections and interpretation of magnetic resonance imaging (MRI) data of the brain and musculoskeletal system to support Rehabilitation Medicine Department (RMD) clinical consultation services, research support services, as well as Section-initiated research, Train others in the use of these techniques for clinical and research purposes.

d. Serve as the Medically Responsible investigator and/ or Associate Investigator on 8 active protocols in RMD and 6 protocols across 9 other Institutes (see list below of current active protocols being supported):

RMD Protocols:

1. 90-CC-0168 A Rigid Body Data Base on Human Movement

2. 11-CC-0246 Characteristics and mechanisms of childhood-onset hemidystonia

3. 10-CC-0073 Physical, Functional and Neural Effects of Two Lower Extremity Exercise

Programs in Children with Cerebral Palsy

4. 03-CC-0060 Virtual Function Anatomy (VFA)

5. T-CC-0346 Vasti Control of Patellofemoral Kinematics in Patients with chronic

Patellofemoral pain. (approved)

6. T-CC-0466 Near-infrared spectroscopy and electroencephalography to assess and train cortical activation during motor tasks

7. T- CC-0426 Reliability and Accuracy of Remote Assessment of Elbow Joint in Neurological

Disorders.

8. 11-CC-0203 Effect or Time varying walking velocity in body-weigth supported treadmill training http://farsite.hill.af.mil/reghtml/regs/far2afmcfars/fardfars/far/12.htm#P282_47557�

Revised 02-10-2014

Other Institute protocols are 13-N-0085, T-N-2515, 93-N-0202, 10-N-0009, 12-N-0104 and 85-N-0195.

e. Perform History and Physical examinations for RMD research subjects who are patients (have a diagnosed movement or musculoskeletal disorder).

f. Collaborate with other investigators who want to utilize RMD resources for their protocols and to assist in protocol design and implementation, interpretation and dissemination.

g. Stimulation of more patient-based research in RMD to investigate pediatric movement disorders, greater research support to other institutes and centers, as well as fostering subject recruitment.

h. Perform other tasks as requested by the Director of FAB and the Chief of RMD.

i. Provide Clinical Research Information System (CRIS) documentation of completed gait consultations requested from RMD.

j. Provide CRIS documentation of National Institute of Neurological Disorders and

Stroke.(NINDS) clinical activities (monthly botulinum toxin clinic)

k. Research collaboration as an associate investigator and/or co-author on scientific publications with NIN-scientists in RMD, the Clinical Center, or other institutes or centers

Please refer to the following attachments in preparing your proposal responding to this solicitation.

Attachment No. 1: Statement of Work Attachment No. 2: Proposal Preparation Instructions Attachment No. 3: Invoice Instructions Attachment No. 4: Security Clauses Attachment No. 5: FAR 52.212-4 Contract Terms and Conditions Commercial Items (FEB 2012)

Attachment No. 6: FAR 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders—Commercial Items (Sept 2013)

Attachment No. 7: Rights in Data—General, (DEC 2007) Attachment No. 8: Control of Infectious Disease under Clinical Center Contracts and Purchase

Orders The following Provisions and Clauses apply to this RFP:

FAR 52.212-1 Instruction to Offerors-/Commercial Items (FEB 2012)(see Attachment No. 2 for additional proposal preparation instructions), FAR 52.212-2 Evaluation – Commercial Items (Jan 1999),

(a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers:

(End of provision)

Evaluation factors are listed in the order of significance for this requirement.

MANDATORY CRITERIA EVALUATION

Failure to adequately document compliance with this mandatory requirement will result in the elimination of the Offerors proposal from further consideration There are no points related to this criteria – this requirement will be evaluated on a pass/fail basis.

MANDATORY REQUIREMENTS

The solicitation contains the following mandatory qualification criteria:

1. Have a medical license to practice in the US

2. Be Board certified in Pediatrics or Pediatric Rehabilitation AND Adult Rehabilitation

AND EMG Diagnostics

3. Have a minimum of 5 years clinical expertise in diagnosis and treatment of patients with complex movement disorders

In determining the best overall proposal, the following criteria will be scored with the corresponding maximum point values for each area, yielding a total of 100 obtainable points.

TECHNICAL EVALUATION CRITERIA 50 Points

Demonstrated experience with interpretation and analysis of 3D gait and movement analysis data.

20 points

Demonstrated experience with in diagnostic ultrasound and ultrasound-guided injections.

30 points

Past Performance 30 points

Demonstrated clinical experience in working with children and adults with cerebral palsy through a resume or Curriculum Vitae (CV) that list past positions that were held, fellowship(s) completed, professional society membership, awards and\or honors received and inclusion on medical and scientific advisory boards

Cost 20 points

The business proposals will be evaluated to determine the reasonableness of the proposed price. The lowest total evaluated price will be assigned 20 points. Points for all other offers will be calculated as follows:

Lowest Total Evaluated ------------------------------------------X 20 Points = Number of points to be assigned Offerors Total Evaluation Price

Total 100 points

Award Criteria

Selection of an Offeror for award will be based on an evaluation of proposals against the evaluation factors specified above. Although technical experience is of paramount consideration in the award, Cost and Cost related factors as well as Past Performance are also important to the overall award decision.

The evaluation will be based on the demonstrated capabilities of the prospective Contractors in relation to the needs of the project as set forth in the RFQ. The merits of each proposal will be evaluated carefully. Each proposal must document the feasibility of successful implementation of the requirements of the RFQ.

FAR 52.212-4 Contract Terms and Conditions Commercial Items (FEB 2012), (refer to attachment number 5)

FAR 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders—Commercial Items (Sept 2013) (refer to attachment number 6).

52.227-14 Rights in Data—General, (DEC 2007) (rfere to attachment number 7 for clause in full text)

The Contractor shall comply with the following Federal Acquisition Regulation (FAR) clauses, which are incorporated in this contract in full text, to implement provisions of law or Executive orders applicable to acquisitions of commercial items.

52.217-5 Evaluation of Options (JULY 1999)

Except when it is determined in accordance with FAR 17.206(b) not to be in the Government’s best interests, the Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. Evaluation of options will not obligate the Government to exercise the option(s).

(End of provision)

FAR 52.217-8 Option to Extend Services (Nov 1999)

The Government may require continued performance of any services within the limits and at the rates specified in the contract. These rates may be adjusted only as a result of revisions to prevailing labor rates provided by the Secretary of Labor. The option provision may be exercised more than once, but the total extension of performance hereunder shall not exceed 6 months. The Contracting Officer may exercise the option by written notice to the Contractor within 30 days from the expiration of the current contract period of performance.

(End of clause) https://acquisition.gov/far/current/html/Subpart%2017_2.html#wp1078150�

52.217-9 Option to Extend the Term of the Contract (Mar 2000)

(a) The Government may extend the term of this contract by written notice to the Contractor within the current period of performance; provided that the Government gives the Contractor a preliminary written notice of its intent to extend at least 30 days before the contract expires. The preliminary notice does not commit the Government to an extension.

(b) If the Government exercises this option, the extended contract shall be considered to include this option clause.

(c) The total duration of this contract, including the exercise of any options under this clause, shall not exceed 60 months.

(End of clause)

Contracting Officer’s Representative

The following Contracting Officer Technical Representative (COR) will represent the Government for the purpose of this contract:

To be determined at the time of award.

The COR is responsible for: (1) monitoring the Contractor's technical progress, including the surveillance and assessment of performance and recommending to the Contracting Officer changes in requirements; (2) interpreting the statement of work and any other technical performance requirements; (3) performing technical evaluation as required; (4) performing technical inspections and acceptances required by this contract; and (5) assisting in the resolution of technical problems encountered during performance.

The Contracting Officer is the only person with authority to act as agent of the Government under this contract. Only the Contracting Officer has authority to: (1) direct or negotiate any changes in the statement of work; (2) modify or extend the period of performance; (3) change the delivery schedule; (4) authorize reimbursement to the Contractor for any costs incurred during the performance of this contract; or (5) otherwise change any terms and conditions of this contract.

The Government may unilaterally change its COTR designation.

Post Award evaluation of Contractor Performance

a) Contractor Performance Evaluations

Interim and final evaluations of Contractor performance will be prepared on this contract in accordance with FAR 42.15. The final performance evaluation will be prepared at the time of completion of work. In addition to the final evaluation, interim evaluation(s) shall be submitted at the time of the annual evaluation. Interim and final evaluations will be provided to the Contractor as soon as practicable after completion of the evaluation.

The Contractor will be permitted thirty days to review the document and to submit additional information or a rebutting statement. If agreement cannot be reached between the parties, the matter will be referred to an individual one level above the Contracting Officer, whose decision will be final. Copies of the evaluations Contractor responses and review comments, if any, will be retained as part of the contract file, and may be used to support future award decisions.

b) Electronic Access to Contractor Performance evaluations

Contractors that have internet capability may access evaluations through a secure Web site for review and comment by completing the registration form that can be obtained at the following address: hhtp://oamp.od.nih./OD/CPS/cps.asp. The registration process requires the Contractor to identify an individual that will serve as a primary point of contact and who will be authorized access to the evaluations for review and comment. In addition, the Contractor will be required to identify an alternate contact that will be responsible for notifying the cognizant contracting official in the event the primary contact is unavailable to process the evaluation within the required 30-day time frame.

Reporting Matters Involving Fraud, Waste and Abuse

Anyone who becomes aware of the existence or apparent fraud, waste and abuse in NIH funded programs is encouraged to report such matters to the HHS Inspector general’s Office in writing or the Inspector general’s hotline. The toll free number is 1-800-HHS-TIPS (1-800-447-8477). All telephone calls will be handled confidentially. The email address is Htips@os.dhhs.gov and the mailing address is:

Office of the Inspector general Department of Health and Human Services

TIPS HOTLINE

PO Box 23489 Washington, DC 20026

ADDITIONAL PROPOSAL INSTRUCTIONS:

Full text copies of the representations and certifications for the other cited provisions and clauses may be obtained online at the NCI website at http://amb.nci.nih.gov.

Additional proposal preparation instructions are delineated in Attachment No. 2 to this combined solicitation /synopsis. Please note that Offerors must either complete FAR 52.212-3, Offerors Representation and Certifications – Commercial Items (Aug 2009) or provide a copy of the valid certifications registrations and Representation and Certifications from System of Award Management Applications (SAM) with their technical/business proposal submission.

Questions regarding this combined synopsis/solicitation must be received in this office by March 4, 2014. Offers must be received by 10:00 AM. (EST) March 12, 2014. Facsimile submissions are not authorized and collect calls will not be accepted.

Submit offers to:

Mr. Brian J. Lind Contract Specialist National Institutes of Health Clinical Center Department of Purchasing and Contracts 6707 Democracy Boulevard Suite 106F Bethesda, MD 20892 mailto:Htips@os.dhhs.gov� http://amb.nci.nih.gov/�

Please reference the solicitation number CC-P14-001231 on your offer. Requests for information concerning this requirement are to be addressed to Brian Lind via e-mail only to lindbj@cc.nih.gov prior to the closing date for questions.

mailto:lindbj@cc.nih.gov�